ACON | Aclarion, Inc.

Index- P/E- EPS (ttm)-1.02 Insider Own2.40% Shs Outstand7.87M Perf Week61.90%
Market Cap8.10M Forward P/E- EPS next Y-0.38 Insider Trans25.19% Shs Float5.21M Perf Month20.00%
Income-8.00M PEG- EPS next Q- Inst Own2.90% Short Float / Ratio1.98% / 0.05 Perf Quarter42.56%
Sales0.06M P/S133.99 EPS this Y-72.50% Inst Trans186.89% Short Interest0.10M Perf Half Y32.40%
Book/sh0.23 P/B4.43 EPS next Y- ROA-217.70% Target Price3.00 Perf Year-20.00%
Cash/sh0.19 P/C5.40 EPS next 5Y- ROE- 52W Range0.38 - 2.37 Perf YTD75.86%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-56.96% Beta-
Dividend %- Quick Ratio1.40 Sales past 5Y- Gross Margin- 52W Low168.42% ATR0.16
Employees7 Current Ratio1.40 Sales Q/Q88.00% Oper. Margin- RSI (14)62.80 Volatility27.09% 13.38%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.14 Prev Close1.03
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.98M Price1.02
Recom2.00 SMA2036.73% SMA5034.03% SMA20026.98% Volume274,514 Change-0.97%
May-30-23 07:30AM
May-23-23 07:30AM
May-19-23 07:30AM
May-11-23 12:41PM
07:00AM Loading…
May-02-23 07:00AM
Apr-28-23 11:20AM
Apr-24-23 07:00AM
Mar-07-23 09:19AM
Feb-16-23 07:00AM
Feb-15-23 07:00AM
Feb-05-23 08:50AM
Jan-31-23 10:01AM
Jan-17-23 08:29AM
10:36AM Loading…
Dec-22-22 10:36AM
Dec-21-22 10:23AM
Dec-19-22 08:33AM
Dec-01-22 09:41AM
Nov-16-22 05:12AM
Oct-25-22 07:00AM
Oct-24-22 07:00AM
Oct-12-22 07:00AM
Oct-10-22 07:05AM
Oct-03-22 07:03AM
Sep-19-22 07:03AM
Aug-04-22 07:00AM
Jul-22-22 09:01AM
Jul-20-22 07:00AM
Jun-22-22 07:00AM
09:15PM Loading…
Apr-26-22 09:15PM
Apr-21-22 07:45PM
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thramann Jeffrey JohnExecutive ChairmanFeb 16Buy1000.0011,0001Feb 21 04:02 PM
Lorbiecki John PaulChief Financial OfficerDec 29Buy0.4522,40410,00022,404Dec 29 06:27 PM
Ness BrentChief Executive OfficerDec 29Buy0.5416,2118,80719,500Dec 29 07:57 PM
Ness BrentChief Executive OfficerDec 28Buy0.422,2899613,289Dec 29 07:57 PM